Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL2000191	重组人II型肿瘤坏死因子受体-抗体融合蛋白注射液		Injection	Biological Products(13)	New Drug Application	2020-07-04	海正生物制药有限公司	Hisun Biopharmaceutical Co Ltd	In Review	2020-07-03	view
CYSB2000030	阿达木单抗注射液	adalimumab	Injection	Biological Products	Supplementary Application	2020-02-29	海正生物制药有限公司	Hisun Biopharmaceutical Co Ltd	Certificate Issued	2020-05-15	view
CYSB2000362	阿达木单抗注射液	adalimumab	Injection	Biological Products	Supplementary Application	2020-12-18	海正生物制药有限公司	Hisun Biopharmaceutical Co Ltd	Certificate Issued	2021-03-10	view
CYSB2000141	阿达木单抗注射液	adalimumab	Injection	Biological Products	Supplementary Application	2020-06-11	海正生物制药有限公司	Hisun Biopharmaceutical Co Ltd	Certificate Issued	2020-08-21	view
CYSB2000361	阿达木单抗注射液	adalimumab	Injection	Biological Products	Supplementary Application	2020-12-18	海正生物制药有限公司	Hisun Biopharmaceutical Co Ltd	Certificate Issued	2021-02-18	view
CXSS2000020	注射用英夫利西单抗	infliximab	Lyophilized	Biological Products(2)	New Drug Application	2020-05-15	海正生物制药有限公司	Hisun Biopharmaceutical Co Ltd	Certificate Issued	2021-09-28	view
CXSS2000027	贝伐珠单抗注射液	bevacizumab	Injection	Biological Products(2)	New Drug Application	2020-06-17	海正生物制药有限公司,贝达药业股份有限公司		Certificate Issued	2021-11-30	view